Incyte's Accumulated Expenses fell 1489.6% to $1.0 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $1.0 billion, marking a year-over-year decrease of 1489.6%. This contributed to the annual value of $1.0 billion for FY2025, which is 1489.6% down from last year.
As of Q4 2025, Incyte's Accumulated Expenses stood at $1.0 billion, which was down 1489.6% from $948.4 million recorded in Q3 2025.
Over the past 5 years, Incyte's Accumulated Expenses peaked at $1.4 billion during Q1 2025, and registered a low of $413.1 million during Q2 2021.
Over the past 5 years, Incyte's median Accumulated Expenses value was $823.0 million (recorded in 2023), while the average stood at $827.0 million.
Its Accumulated Expenses has fluctuated over the past 5 years, first soared by 4522.61% in 2022, then plummeted by 1713.42% in 2025.
Quarter analysis of 5 years shows Incyte's Accumulated Expenses stood at $533.6 million in 2021, then skyrocketed by 31.38% to $701.1 million in 2022, then surged by 33.45% to $935.6 million in 2023, then grew by 29.55% to $1.2 billion in 2024, then dropped by 14.9% to $1.0 billion in 2025.
Its last three reported values are $1.0 billion in Q4 2025, $948.4 million for Q3 2025, and $857.1 million during Q2 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value